TipRanks
Go Ultimate55% OFF

Doyle Mittie Insider Profile

4 Followers

Doyle Mittie, CMO at Avalo Therapeutics, holds 51.78K shares in Avalo Therapeutics (Ticker: AVTX), holds ― shares in Cullinan Management (Ticker: CGEM), holds ― shares in Dice Therapeutics (Ticker: ~DICE).

Doyle Mittie's Trading History

AVTX
Avalo Therapeutics
Sep 01, 2026CMOUninformative Buy5.46K$371.23K
~DICE
Dice Therapeutics
――――
CGEM
Cullinan Management
―Director――

You May Also Like

Doyle Mittie insider profile FAQ

What stocks does Doyle Mittie hold?
Doyle Mittie holds: AVTX, CGEM, ~DICE stocks.
What was Doyle Mittie’s latest transaction?
Doyle Mittie’s latest transaction was an Uninformative Buy of $5.46K.
What is Doyle Mittie's role in Avalo Therapeutics?
Doyle Mittie's role in Avalo Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.